Harrow, Inc. Contract Liability (Deferred Revenue)
Harrow, Inc. (HROW) had Contract Liability (Deferred Revenue) of $106.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-10
- 2026-06-30: Contract with Customer, Liability, Current $106.00K.
- 2026-03-31: Contract with Customer, Liability, Current $149.00K.
- 2025-12-31: Contract with Customer, Liability, Current $788.00K.
- 2025-09-30: Contract with Customer, Liability, Current $345.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $106.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $149.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $788.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $345.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $91.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $145.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $44.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $137.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $248.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $112.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $75.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $153.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $132.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $67.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $113.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $115.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $83.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $23.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $16.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $3.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $56.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $3.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $66.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $63.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $53.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $60.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $57.00K 10-K · filed 2021-03-08 |
| 2019-09-30 | $48.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $224.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $359.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $119.00K 10-K · filed 2020-03-13 |
| 2017-12-31 | $29.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |